Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Patient Advocacy and Community Engagement Coordination

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks to lead the development and management of a Patient Advocacy Panel tasked with embedding patient perspectives into all stages of research activities under the NFRA, including planning, meetings, and dissemination. The role involves coordinating with patients, caregivers, and community stakeholders to ensure their voices directly influence research design and outcomes, fostering meaningful engagement and trust. Success will be measured by the panel’s impact on research relevance, inclusivity, and public accountability, with expectations for structured meetings, feedback integration, and transparent communication channels. The position is structured as a subcontract under the Defense Health Agency Contracting Activity, aligned with NAICS code 813930, and requires full compliance with federal contracting standards. Proposals must be submitted by September 14, 2026, with the work expected to unfold within a collaborative, mission-driven framework centered on improving health research through lived experience. While specific location details are not specified, performance will occur in alignment with the agency’s broader objectives, leveraging expertise in community engagement and patient-centered research methodologies.

General Info

Lead patient advocacy panel to embedding lived experience into NFRA research through structured engagement and transparent communication.

Agency

Department Of Defense → Defense Health Agency Contracting Activity - DhacaView Agency

NAICS

813930 - Labor Unions and Similar Labor OrganizationsView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Lead the development and management of the Patient Advocacy Panel (PAP) to integrate patient perspectives into research planning, meetings, and dissemination efforts within the NFRA.

Similar Contracts

Same NAICS industry code

NAICS: 813930
Grant
Ensuring “Pro-American Worker” Critical Minerals Supply Chain in the Western HemisphereThe U.S. Department of Labor’s Bureau of International Labor Affairs is forecasting a future funding opportunity aimed at strengthening the “Pro-American Worker” critical minerals supply chain within the Western Hemisphere. This initiative seeks to promote secure, ethical, and domestically aligned mineral sourcing and processing by supporting projects that advance labor standards, workforce development, and supply chain resilience across partner countries in the region. The program is not yet open for applications, with the forecast posted on July 16, 2026, and no solicitation number assigned at this time. Interested parties are encouraged to subscribe to Grants.gov for official updates as the opportunity develops. The North American Industry Classification System code associated with this opportunity is 813930, indicating a focus on organizational and advocacy services possibly linked to labor or industry standards. There is no set-aside designation specified, meaning the opportunity is not restricted to specific types of applicants such as small businesses or nonprofits. Point of contact for inquiries is Sue Levenstein, reachable via email at ogm_ilab@dol.gov or phone at 877-872-5627. Due to the preliminary nature of the forecast, detailed guidance on eligibility, budget ranges, or application requirements is not yet available, and the agency advises prospective applicants to rely on Grants.gov for future official announcements. The performance location is not specified, implying potential international scope across Western Hemisphere nations with a clear alignment to U.S. labor and economic interests.
Bureau Of International Labor Affairs

POSTED

24 days ago

DEADLINE

N/A
View Details
NAICS: 813930
Grant
Patient Advocacy and Community Engagement CoordinationThe contract seeks to establish and manage partnerships between researchers and patient advocacy groups to enhance collaboration in health-related initiatives, with a focus on building sustainable community engagement structures and actionable engagement plans. It emphasizes the development of frameworks that ensure meaningful involvement of patient communities in research processes, aiming to align scientific objectives with real-world patient needs and perspectives. The effort is designed to foster trust, improve communication, and integrate community input into the design and implementation of research activities under the purview of the Department of Defense. This subcontract, issued under NAICS code 813930 by the Department of the Army through USAMRAA, is open for responses until November 18, 2026, with no specific set-aside provisions indicated. The work does not specify a physical place of performance, suggesting flexibility in execution, potentially across multiple locations or virtually. The initiative is part of broader efforts within the Department of Defense to strengthen public health relationships and ensure that research outcomes are both scientifically rigorous and socially resonant. Participation requires demonstrated expertise in bridging academic research with community advocacy, and the ability to create scalable, inclusive engagement models that empower patient voices throughout the research lifecycle.
Department Of The Army -- Usamraa

POSTED

about 2 months ago

DEADLINE

in 3 months
View Details

More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

Same awarding agency

NAICS: 541715
New
Grant
DoW Reconstructive Transplant, Investigator-Initiated Research AwardThe FY26 Reconstructive Transplant Research Program Investigator-Initiated Research Award supports innovative, scientifically rigorous studies aimed at advancing reconstructive transplant research and improving patient outcomes, particularly for military Service Members, Veterans, and their families. Proposals must demonstrate strong scientific rationale and direct military relevance, addressing healthcare needs arising from traumatic injuries, and are expected to contribute meaningfully to short- and long-term advances in the field. Eligible research spans the full spectrum from basic science and preclinical animal models to clinical studies involving human subjects or anatomical tissues, but explicitly excludes clinical trials as defined by federal guidelines. A robust study design with attention to reproducibility, including a statistically sound power analysis, is required to ensure the validity and translational potential of the proposed work. Applicants must include preliminary or published data that directly support the feasibility and relevance of the research to reconstructive transplantation, and projects must align with one or more of the designated FY26 RTRP Focus Areas. While collaboration with military researchers and clinicians is encouraged to enhance relevance and impact, it is not a mandatory requirement. The program is open to investigators across academic, medical, and research institutions who can demonstrate a clear pathway from laboratory findings to improved care and quality of life. Applications should emphasize the potential for broad impact both within the reconstructive transplant community and among the wider population of trauma survivors. All submissions must be made through the eBRAP system with inquiries directed to the designated point of contact.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

5 days ago

DEADLINE

N/A
View Details
NAICS: 541380
Grant
Molecular and Genomic Laboratory TestingThe contract seeks a subcontractor to conduct advanced molecular and genomic testing on tissue samples from individuals with neurofibromatosis, specifically focusing on next-generation sequencing, RNA sequencing, and other related molecular profiling techniques. The work aims to generate detailed genetic and transcriptomic data to enhance understanding of the disease’s molecular mechanisms, with the expectation that results will support clinical or research initiatives tied to defense health programs. All testing must adhere to high standards of accuracy, reproducibility, and data integrity, with samples received from designated sources and processed under protocols that ensure traceability and quality control. The opportunity is posted under NAICS code 541380, indicating it is classified as other scientific and technical consulting services, and is issued by the Defense Health Agency Contracting Activity under the Department of Defense. Interested parties must submit proposals by the deadline of September 22, 2026, and the work is expected to be performed domestically though the exact location is not specified. The contract does not include set-aside provisions for small businesses or other designated categories, and there is no designated point of contact listed in the posting. Proposals should demonstrate technical expertise in genomic analysis, experience with clinical or research-grade tissue samples, and the capacity to deliver actionable data within stringent timelines.
Testing Laboratories and Services

POSTED

about 1 month ago

DEADLINE

in about 1 month
View Details
NAICS: 541611
Grant
Clinical Trial Design and Biostatistical SupportThe contract seeks a subcontractor to provide comprehensive biostatistical consulting services in support of clinical and translational research initiatives, with a focus on study design, power analysis, randomization procedures, and the development of robust data analysis plans. The work is intended to ensure methodological rigor and statistical validity across defense-related health research projects, requiring expertise in applying statistical principles to real-world clinical trial scenarios. The contractor must be capable of tailoring statistical methodologies to the unique constraints and objectives of military and veteran health research environments. This opportunity is issued under the Defense Health Agency Contracting Activity, operating within the Department of Defense, and is classified under NAICS code 541611 for scientific research and development services. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026. Performance location details are not specified, indicating potential flexibility in execution, though the work must align with the Agency’s operational and research priorities. As a subcontract, this engagement is likely part of a larger research initiative, and proposers should be prepared to collaborate effectively with primary contractors and federal research teams to deliver timely, high-quality statistical support.
Administrative Management and General Management Consulting Services

POSTED

about 1 month ago

DEADLINE

in about 1 month
View Details
NAICS: 541711
Grant
Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.
Research and Development in Biotechnology

POSTED

about 1 month ago

DEADLINE

in about 1 month
View Details